Korean J Hosp Palliat Care.  2017 Jun;20(2):131-135. 10.14475/kjhpc.2017.20.2.131.

Opioid Withdrawal Symptoms after Conversion to Oral Oxycodone/Naloxone in Advanced Cancer Patients Receiving Strong Opioids

Affiliations
  • 1Department of Hematology-Oncology, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea. newatp@naver.com

Abstract

PURPOSE
Oral naloxone is combined with oxycodone to alleviate or prevent opioid-induced constipation in cancer pain patients. However, there is still concern that oral naloxone may precipitate opioid withdrawal symptoms in patients on opioids. We retrospectively investigated clinical characteristics of cancer patients who experienced opioid withdrawal symptoms.
METHODS
We reviewed medical records of all patients who were prescribed with oral oxycodone/naloxone at a tertiary cancer center from January 1, 2012 through December 31, 2016. Eligible patients were screened based on demographics, opioid and naloxone dosages, clinical manifestation and pain intensity.
RESULTS
Among a total of 1,641 patients, 10 patients were selected. Seven patients were male, and the average age was 68.1 years. The median dose of naloxone that induced withdrawal symptoms was 20 mg. Most common withdrawal symptom was shivering (seven patients) followed by cold sweating (five), and muscle twitching (five). Other symptoms included restlessness, fever, dizziness, and yawning. Pain was exacerbated from the median intensity of numeric rating scale (NRS) 3 to NRS 6.
CONCLUSION
Opioid withdrawal symptoms may occur when switching to oral oxycodone/naloxone for cancer patients who have been treated with other strong opioids. A prospective, multicenter study on this issue should be conducted in future.

Keyword

Naloxone; Oxycodone naloxone combination; Substance withdrawal symptoms; Opioid analgesics

MeSH Terms

Analgesics, Opioid*
Constipation
Demography
Dizziness
Fever
Humans
Male
Medical Records
Naloxone
Oxycodone
Prospective Studies
Psychomotor Agitation
Retrospective Studies
Shivering
Substance Withdrawal Syndrome*
Sweat
Sweating
Yawning
Analgesics, Opioid
Naloxone
Oxycodone
Full Text Links
  • KJHPC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr